Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells Exosomes for the Treatment of Trigeminal Neuralgia

NCT05152368 is registered in ClinicalTrials.gov with The Foundation for Orthopaedics and Regenerative Medicine as lead sponsor.

NCT NCT05152368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05152368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells Exosomes for the Treatment of Trigeminal Neuralgia
Lead sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Phase
Phase 1
Overall status
Recruiting
Start date
September 9, 2022
Completion date
January 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy, trigeminal neuralgia